A Phase II trial of suramin monthly × 3 for hormone-refractory prostate carcinoma-Reference-Cited by-同舟云学术

A Phase II trial of suramin monthly × 3 for hormone-refractory prostate carcinoma

Published:2003-11-10 Issue:1 Volume:100 Page:65-71
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Vogelzang Nicholas J.,Karrison Theodore,Stadler Walter M.,Garcia Juan,Cohn Helene,Kugler John,Troeger Thomas,Giannone Leonard,Arrieta Rose,Ratain Mark J.,Vokes Everett E.

Funder

National Cancer Institute (NCI)

Early Therapeutics Development with Phase II Emphasis

University of Chicago Cancer Research Center

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference34 articles.

1. Global cancer statistics in the year 2000;Parkin;Lancet Oncol,2001

2. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941;Huggins;J Urol,2002

3. Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial;Vogelzang;Urology,1995

4. Second-line hormonal therapy for advanced prostate cancer: a shifting paradigm;Small;J Clin Oncol,1997

5. Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer;Kelly;J Clin Oncol,1993

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suramin, a drug for the treatment of trypanosomiasis, reduces the prothrombotic and metastatic phenotypes of colorectal cancer cells by inhibiting hepsin;Biomedicine & Pharmacotherapy;2023-12

2. The role of calcium channels in prostate cancer progression and potential as a druggable target for prostate cancer treatment;Critical Reviews in Oncology/Hematology;2023-06

3. Flavivirus proteases: The viral Achilles heel to prevent future pandemics;Antiviral Research;2023-02

4. Suramin and NF449 are IP5K inhibitors that disrupt inositol hexakisphosphate–mediated regulation of cullin–RING ligase and sensitize cancer cells to MLN4924/pevonedistat;Journal of Biological Chemistry;2020-07

5. 100 Years of Suramin;Antimicrobial Agents and Chemotherapy;2020-02-21